Follow
Douglas G Altman
Douglas G Altman
Centre for Statistics in Medicine, University of Oxford
Verified email at csm.ox.ac.uk
Title
Cited by
Cited by
Year
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
D Moher, A Liberati, J Tetzlaff, DG Altman, t PRISMA Group*
Annals of internal medicine 151 (4), 264-269, 2009
164030*2009
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
D Moher, A Liberati, J Tetzlaff, DG Altman, t PRISMA Group*
Annals of internal medicine 151 (4), 264-269, 2009
1361182009
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
D Moher, A Liberati, J Tetzlaff, DG Altman, t PRISMA Group*
Annals of internal medicine 151 (4), 264-269, 2009
1355182009
Statistical methods for assessing agreement between two methods of clinical measurement
JM Bland, DG Altman
The lancet 327 (8476), 307-310, 1986
563431986
Statistical methods for assessing agreement between two methods of clinical measurements
JM Blaud, DG Altman
Lancet 12, 307-310, 1986
563041986
Measuring inconsistency in meta-analyses
JPT Higgins, SG Thompson, JJ Deeks, DG Altman
Bmj 327 (7414), 557-560, 2003
529012003
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
A Liberati, DG Altman, J Tetzlaff, C Mulrow, PC Gøtzsche, JPA Ioannidis, ...
Annals of internal medicine 151 (4), W-65-W-94, 2009
498092009
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
E Von Elm, DG Altman, M Egger, SJ Pocock, PC Gøtzsche, ...
The lancet 370 (9596), 1453-1457, 2007
46223*2007
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
E Von Elm, DG Altman, M Egger, SJ Pocock, PC Gøtzsche, ...
The lancet 370 (9596), 1453-1457, 2007
46214*2007
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
E Von Elm, DG Altman, M Egger, SJ Pocock, PC Gøtzsche, ...
The lancet 370 (9596), 1453-1457, 2007
46090*2007
The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials
JPT Higgins, DG Altman, PC Gøtzsche, P Jüni, D Moher, AD Oxman, ...
Bmj 343, 2011
281972011
Practical statistics for medical research
DG Altman
Chapman and Hall/CRC, 1990
256421990
Heart disease and stroke statistics—2017 update: a report from the American Heart Association
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ...
circulation 135 (10), e146-e603, 2017
168562017
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies
PF Whiting, AWS Rutjes, ME Westwood, S Mallett, JJ Deeks, JB Reitsma, ...
Annals of internal medicine 155 (8), 529-536, 2011
112732011
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
JAC Sterne, MA Hernán, BC Reeves, J Savović, ND Berkman, ...
bmj 355, 2016
110592016
Measuring agreement in method comparison studies
JM Bland, DG Altman
Statistical methods in medical research 8 (2), 135-160, 1999
100551999
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials
D Moher, KF Schulz, DG Altman
The lancet 357 (9263), 1191-1194, 2001
98122001
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration
JP Vandenbroucke, E Elm, DG Altman, PC Gøtzsche, CD Mulrow, ...
Annals of internal medicine 147 (8), W-163-W-194, 2007
97642007
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials
D Moher, KF Schulz, DG Altman
The lancet 357 (9263), 1191-1194, 2001
96622001
Assessing risk of bias in included studies
JPT Higgins, DG Altman
Cochrane handbook for systematic reviews of interventions: Cochrane book …, 2008
8596*2008
The system can't perform the operation now. Try again later.
Articles 1–20